Literature DB >> 8829307

Disseminated Blastoschizomyces capitatus infection in acute myeloblastic leukaemia. Report of three cases.

M A Sanz1, F López, M L Martínez, G F Sanz, J A Martínez, G Martín, M Gobernado.   

Abstract

Three new cases of Blastoschizomyces capitatus infection occurring in neutropenic patients with acute myeloblastic leukaemia are reported. B. capitatus was isolated from blood cultures in all patients. All three patients were treated with amphotericin B, but only one was cured from the infection. Our study confirms the emergence of B. capitatus as an opportunistic agent of disseminated fungal infection in leukaemic patients.

Entities:  

Mesh：

Year:  1996        PMID： 8829307     DOI： 10.1007/bf01358882

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


  13 in total

1.  Isolated meningitis caused by Blastoschizomyces capitatus.

Authors:  A B Naficy; H W Murray
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

2.  Trichosporon capitatum fungemia and intravenous drug abuse.

Authors:  S Moreno; L Buzón; A Sánchez-Sousa
Journal:  Rev Infect Dis       Date:  1987 Nov-Dec

3.  [Lethal septicemia caused by Trichosporon sp. in 3 immunosuppressed patients].

Authors:  M Wolff; Y Curran; A Bure; P Legrand; C Marche; B Regnier; E Drouhet; F Vachon
Journal:  Presse Med       Date:  1986-06-21       Impact factor: 1.228

4.  Fungal infection and fever of unknown origin in neutropenic patients.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1986-05-30       Impact factor: 4.965

5.  Systemic infection with Trichosporon capitatum in two patients with acute leukaemia.

Authors:  D R Baird; M Harris; R Menon; R W Stoddart
Journal:  Eur J Clin Microbiol       Date:  1985-02       Impact factor: 3.267

6.  Trichosporon capitatum causing recurrent fungal endocarditis.

Authors:  A G Arnold; B Gribbin; M De Leval; F Macartney; M Slack
Journal:  Thorax       Date:  1981-06       Impact factor: 9.139

7.  Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients.

Authors:  P Martino; M Venditti; A Micozzi; G Morace; L Polonelli; M P Mantovani; M C Petti; V L Burgio; C Santini; P Serra
Journal:  Rev Infect Dis       Date:  1990 Jul-Aug

Review 8.  Trichosporonosis in patients with neoplastic disease.

Authors:  T J Walsh; K R Newman; M Moody; R C Wharton; J C Wade
Journal:  Medicine (Baltimore)       Date:  1986-07       Impact factor: 1.889

9.  Experimental infection in the rabbit with Trichosporon capitaum.

Authors:  W R GILBERT; B F FETTER
Journal:  J Bacteriol       Date:  1962-11       Impact factor: 3.490

10.  Disseminated Trichosporon capitatum infection in an immunosuppressed host.

Authors:  D J Winston; G E Balsley; J Rhodes; S R Linné
Journal:  Arch Intern Med       Date:  1977-09
View more
  3 in total

Review 1.  Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature.

Authors:  Corrado Girmenia; Livio Pagano; Bruno Martino; Domenico D'Antonio; Rosa Fanci; Giorgina Specchia; Lorella Melillo; Massimo Buelli; Giampaolo Pizzarelli; Mario Venditti; Pietro Martino
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

2.  Genotyping and antifungal susceptibility profile of Dipodascus capitatus isolates causing disseminated infection in seven hematological patients of a tertiary hospital.

Authors:  Ignacio Gadea; Manuel Cuenca-Estrella; Elena Prieto; Teresa M Diaz-Guerra; Jose I Garcia-Cia; Emilia Mellado; Jose F Tomas; Juan L Rodriguez-Tudela
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

Review 3.  Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature.

Authors:  Aygul Dogan Celik; Resat Ozaras; Serda Kantarcioglu; Ali Mert; Fehmi Tabak; Recep Ozturk
Journal:  Rheumatol Int       Date:  2009-04-16       Impact factor: 2.631
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.